Genomic Mechanisms of Neoplastic Diseases

  • Domnita Crisan

Part of the Molecular and Translational Medicine book series (MOLEMED)

Table of contents

  1. Front Matter
    Pages i-xii
  2. Bobby L. Boyanton Jr, Jennifer R. Rushton
    Pages 1-38
  3. Karen P. Mann, Debra F. Saxe
    Pages 127-155
  4. Sophia L. Yohe, David W. Bahler, Marsha C. Kinney
    Pages 157-214
  5. Daniela Hoehn, L. Jeffrey Medeiros, Sergej Konoplev
    Pages 255-291
  6. Barbara Zehnbauer, Mona Nasser
    Pages 293-323
  7. Muller Fabbri, George A. Calin
    Pages 325-340
  8. Back Matter
    Pages 341-358

About this book


Hematopathology: Genomic Mechanisms of Neoplastic Diseases will keep physicians abreast of the rapid and complex changes in genomic medicine, as exemplified by the molecular pathology of hematologic malignancies. This timely volume will update physicians on the complexities of genomic lesions, as well as offer an integrated framework encompassing molecular diagnosis, the new WHO classification of hematologic  neoplasms with focus on molecular pathology, prognostic value of molecular tests, and molecular monitoring of response to gene-targeted therapy. As such, it will be of great value to hematologists, oncologists, pathologists, internal medicine and pediatric specialists, as well as bioscientific staff and laboratorians in private hospitals and academic institutions.


Cytogenetics Hematologic Malignancies Molecular Diagnostics Molecular Medicine Personalized Medicine Translational Medicine

Editors and affiliations

  • Domnita Crisan
    • 1
  1. 1., Department of Clinical PathologyWilliam Beaumont HospitalRoyal OakUSA

Bibliographic information

  • DOI
  • Copyright Information Springer Science+Business Media, LLC 2011
  • Publisher Name Humana Press, Totowa, NJ
  • eBook Packages Medicine Medicine (R0)
  • Print ISBN 978-1-60761-261-2
  • Online ISBN 978-1-60761-262-9
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals